Kiwi Wealth Investments Limited Partnership Dexcom Inc Transaction History

Kiwi Wealth Investments Limited Partnership

$126 Million
Q4 2023

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 17, 2021	SELL	$80.99 - $107.93 $1.72 Million - $2.3 Million	-21,280 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$84.79 - $104.74 $1.8 Million - $2.23 Million	21,280 New	21,280 $7.65 Million
Q4 2020 Feb 17, 2021	SELL	$78.0 - $104.5 $630,786 - $845,091	-8,087 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $54,918 - $64,946	575 Added 7.65%	8,087 $3.33 Million
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $91,011 - $152,953	-1,452 Reduced 16.2%	7,512 $3.05 Million
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $428,389 - $677,947	8,964 New	8,964 $2.41 Million
Q3 2019 Nov 13, 2019	SELL	$35.53 - $43.8 $605,360 - $746,264	-17,038 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$27.84 - $38.92 $474,337 - $663,118	17,038 New	17,038 $2.55 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kiwi Wealth Investments Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Kiwi Wealth Investments Limited Partnership with notifications on news.

Account